T1	p 114 180	patients with acute myeloid leukemia and myelodysplastic syndromes
T2	p 185 193	Japanese
T3	p 394 505	patients with acute myeloid leukemia ( AML ) or myelodysplastic syndromes ( MDS ) during and after chemotherapy
T4	p 1337 1387	patients with AML or MDS who received chemotherapy
T5	i 33 45	itraconazole
T6	i 59 70	fluconazole
T7	i 338 349	fluconazole
T8	i 366 378	itraconazole
T9	i 574 586	itraconazole
T10	i 649 660	fluconazole
T11	o 669 683	Adverse events
T12	o 832 863	probable or possible infections
T13	o 1122 1144	frequency of infection